West Virginia has had the highest drug overdose death rate in the country since at least 2014, according to CDC data.
According to a 2026 analysis from KFF using CDC data, West Virginia had the highest opioid overdose death rate in the country in 2024, at 38.6 deaths per 100,000 people. The state also saw one of the largest declines in overdose deaths that year, with a drop of about 46%.
But even with that progress, the situation is still serious.
Overdose deaths in West Virginia began to decline in 2024 and continued into 2025. State officials reported a drop of around 40% in recent data. This lines up with national research showing that West Virginia had one of the largest declines in the country.
If you want to see how other states compare, you can check out our overview of states with the worst drug problems.
This article looks at the deeper reasons behind West Virginia’s overdose crisis. These include historical, economic and geographic factors that have built up over time. It also explains why those factors are still affecting the state today, even as the numbers begin to improve.
The Current Data
Provisional CDC data shows that overdose deaths in West Virginia dropped sharply between 2024 and 2025. Data tables indicate a decline from about 1,351 deaths to about 787 over a 12-month period.
This reflects a major decline in overdose deaths. Overall, data from multiple sources shows that deaths in West Virginia fell by roughly 35% to 45% during this period, depending on how the data is measured.
Progress With Ongoing Concerns
Even with that improvement, experts say the crisis is far from over. A leader at West Virginia University’s Rockefeller Neuroscience Institute said he was “encouraged” by the progress, but also warned that the state still “leads the nation by far” in overdose deaths.
Looking at the long-term trend shows how quickly things escalated.
In 2001, West Virginia recorded 23 overdose deaths per 100,000 people. By 2020, that number had risen to about 81 per 100,000. That’s more than three times higher.
This increase was largely driven by the rise of fentanyl, which hit West Virginia especially hard. A 2024 policy analysis found that since 1999, the state’s overdose death rate in 2022 had increased by about 1,680%.
Changing Drug Trends
The types of drugs involved have also changed over time.
- Fentanyl and similar synthetic opioids were involved in 76% of overdose deaths in 2021, up from 58% in 2017
- Methamphetamine-related deaths rose from 22.8% in 2017 to 52.2% in 2021
- Heroin-related deaths dropped from 26.3% to 3% during the same period
This shift is important.
West Virginia’s overdose crisis is no longer mainly driven by prescription opioids. Today, it’s dominated by illicit synthetic drugs. Many people are also using more than one drug at the same time. This is called polysubstance use, and it often involves fentanyl combined with methamphetamine.
How West Virginia Got Here: The Historical Record
A Working-Class State Built on Physical Labor
To understand West Virginia’s overdose crisis, it helps to start with the state’s history.
For decades, much of the workforce has been concentrated in physically demanding jobs like coal mining, timber and chemical manufacturing. These jobs require intense manual labor and often lead to serious, long-term injuries.
At its peak in 1985, the coal industry alone employed nearly 180,000 workers nationwide, with a large share of those jobs in West Virginia.
Over time, this kind of work took a toll on workers’ bodies. Many developed chronic pain from injuries, black lung disease or years of heavy equipment use. This created a large group of working-age adults who needed ongoing pain management.
The Rise of Opioid Prescribing
That’s where the next phase of the crisis began.
In the late 1990s, pharmaceutical companies started promoting opioids like OxyContin as a safe option for chronic pain. At the time, these drugs were marketed as having a low risk of addiction — claims that have since been challenged in court.
West Virginia’s workforce made the state especially vulnerable to this shift. Many residents already had legitimate pain conditions, which made opioid prescriptions more common.
At its peak, the state’s opioid prescribing rate reached 129.5 prescriptions per 100 people. That’s more than double the national average of 58.7 per 100. West Virginia ranked No. 1 in the country by this measure.
The Pill Mill Era and Pharmaceutical Flooding
In the 2000s and early 2010s, West Virginia became the center of one of the most serious public health failures in modern U.S. history.
During this time, drug distributors shipped 780 million hydrocodone and oxycodone pills into the state between 2006 and 2012. This happened in a state with fewer than 2 million residents.
In some areas, the numbers were extreme. In Mingo County, the volume of pills was so high that it was described as the “opioid capital of America.”
One example shows how severe the problem was. A small pharmacy in Kermit, West Virginia — serving a town of about 400 people — received 2.2 million hydrocodone pills and 78,500 oxycodone pills in just one year from a single distributor.
How the System Broke Down
This didn’t happen by chance. It was the result of failures across the entire supply chain:
- Distributors were required by law to report suspicious orders, but many did not
- Pharmacies continued filling prescriptions at unusually high volumes
- “Pill mills” operated openly, often prescribing opioids with little or no proper medical evaluation
Federal regulators were aware of these patterns. The DEA had access to distribution data for years but did not release it publicly right away. When the data was finally made public through a court order, it showed that 76 billion opioid pills had been shipped across the U.S. between 2006 and 2012. West Virginia received a disproportionate share.
The Impact on West Virginia
The impact on the state was severe.
During this period, 1,728 people in West Virginia died from overdoses involving hydrocodone and oxycodone alone. The economic damage was also significant. A 2016 analysis estimated the state lost nearly $8.8 billion in GDP due to the opioid crisis — about $4,793 per person.
The Transition to Heroin and Then Fentanyl
In 2016, the CDC tightened opioid prescribing guidelines, and pill mills began to shut down under legal pressure. As a result, prescription opioids became harder to access.
For many people who were already dependent on these medications — often after being prescribed them for real medical needs — this created a new problem. They still needed relief, but the legal supply had decreased.
Many turned to the street drug market instead. Heroin became a common alternative because it was cheaper, easier to find and produced similar effects.
As this shift happened, overdose deaths in West Virginia continued to rise.
The Shift From Heroin to Fentanyl
The heroin phase didn’t last long. It was quickly replaced by fentanyl, a much stronger synthetic opioid. Fentanyl is about 50 to 100 times more potent than morphine. Because of this, it’s cheaper to produce and easier to transport than heroin. It’s also far more dangerous, since even a small amount can cause a fatal overdose.
From 2013 to 2020, the types of drugs involved in overdose deaths changed dramatically:
- Fentanyl-related deaths rose from 7% to 75%
- Heroin-related deaths dropped from 27% to 11%
By 2021, fentanyl or similar synthetic opioids were involved in 76% of all overdose deaths in the state.
How This Played Out on the Ground
One area shows how quickly this transition happened.
Cabell County, including the city of Huntington, had some of the highest overdose death rates in the state. In 2015 alone, the county recorded 202 overdose deaths — more than double the rate of the next-highest county.
Doctors and emergency responders began noticing a major change. Heroin was no longer showing up in toxicology reports. Instead, more dangerous substances began appearing:
- Fentanyl
- Carfentanil (up to 100 times more potent than fentanyl)
- Xylazine (“tranq”), a sedative that naloxone doesn’t reverse
This made overdoses more dangerous and harder to treat.
The Structural Factors That Made West Virginia Uniquely Vulnerable
Poverty and Economic Despair
West Virginia consistently ranks among the poorest states in the country. Its poverty rate reached 19.1% in 2016 and 2017 — when the opioid epidemic was at its worst — and stood at 16.7% as of 2023. By median household income, it’s one of the lowest-ranked states in the nation.
Income inequality within the state is steep. Historically, much of the land and natural resources have been controlled by outside owners, especially coal companies. This limited local economic growth and reduced long-term stability for many communities.
How Economic Conditions Increase Risk
This economic profile is directly linked to overdose risk. Research shows that drug use and overdose deaths are higher in areas with greater income inequality.
Experts often refer to this pattern as “diseases of despair,” which include:
- Drug overdose
- Suicide
- Alcohol-related liver disease
These are closely tied to economic hardship and the loss of stable, meaningful work.
West Virginia has experienced these conditions for decades. Coal employment, which once defined many communities, dropped sharply — from about 180,000 jobs nationally in 1985 to fewer than 40,000 by the mid-2010s.
As those jobs disappeared, communities lost more than employment. Local economies shrank, institutions weakened and a shared sense of purpose began to fade.
Low Educational Attainment
West Virginia ranks last among U.S. states in overall educational attainment, with the lowest proportion of residents holding associate’s or bachelor’s degrees.
Why Education Matters for Recovery
Educational attainment is one of the strongest protective factors against substance use disorder. It’s closely linked to:
- Economic opportunity
- Access to health information
- Social support networks that help people recover
When these supports are limited, the risk of substance use disorder increases.
In West Virginia, this gap adds to the challenges created by poverty and economic decline. It also affects the healthcare system. Lower education levels reduce the number of trained providers available to deliver addiction treatment, contributing to a workforce shortage that remains a major barrier to expanding care.
Rural Geography and Treatment Deserts
West Virginia is one of the most rural states in the country. More than half of its residents live in rural or micropolitan areas. Much of the state is also mountainous, which makes travel difficult and increases the time it takes to reach care.
Before the opioid crisis prompted a larger response, the state had just 197 residential substance use treatment beds for its entire population. Even as treatment capacity expanded, transportation remained a major barrier. In some areas, reaching the nearest facility can take hours of driving on winding mountain roads, especially for people without access to a car.
Barriers to Access in Rural Communities
These challenges go beyond distance. Rural communities also face social and cultural barriers that make treatment harder to access.
In smaller towns, seeking help is often more visible than it would be in a city. This can discourage people from getting care. For example:
- Visiting a treatment clinic: may feel public and exposed
- Picking up naloxone: can carry stigma
- Participating in harm reduction programs: may be noticed by others
Research on West Virginia’s buprenorphine programs also shows that stigma can affect treatment decisions. Some groups in the state:
- Favor abstinence-only approaches: may limit acceptance of certain treatments
- View medication-assisted treatment (MAT) as “drug substitution”: can discourage people from seeking care
These beliefs can make it harder for people to start or continue treatment, even when effective options are available.
The HIV and Hepatitis C Compounding Effect
Intravenous drug use increased significantly in West Virginia, rising from 36% of people who use drugs in 2005 to 54% in 2015. This shift contributed to a second public health crisis: the spread of HIV and hepatitis C.
How Injection Drug Use Increased Health Risks
The CDC identified West Virginia counties as representing 28 of the nation’s 220 most at-risk areas for HIV and hepatitis C outbreaks linked to injection drug use. That’s about 14% of the total — from a state that makes up less than 0.6% of the U.S. population.
In 2021, Kanawha County alone recorded 153 new HIV cases. By 2023, that number had dropped to 100, a decline partly linked to expanded harm reduction services.
This trend shows how quickly these infections can spread — and how difficult they can be to control.
- Injection drug use increases the risk of sharing needles
- Shared equipment can spread HIV and hepatitis C
- These infections make treatment more complex and long-term
The hepatitis C burden in West Virginia remains especially high. This adds another layer of strain to an already overwhelmed healthcare system.
The Current Drug Supply: Fentanyl, Methamphetamine and Polysubstance Use
West Virginia’s overdose crisis in 2024 and 2025 looks very different from the prescription pill crisis of the early 2000s. These changes have created new challenges for both treatment and policy.
Fentanyl Dominates the Drug Supply
Fentanyl is now found in nearly all illicit opioid use in the state. Heroin is rarely seen in toxicology reports. Most fentanyl is illegally manufactured and often mixed with other substances, including carfentanil.
Fentanyl also behaves differently than earlier opioids. Its effects are shorter, about 30 to 60 minutes compared to four to five hours for heroin. This leads to:
- More frequent use throughout the day
- Increased sharing of injection equipment
- Higher risk of infectious disease spread
Fentanyl also presents challenges for treatment. Standard doses of buprenorphine may be less effective, making medication-assisted treatment more complex.
The Rise of Methamphetamine Use
Methamphetamine has become another major driver of overdose deaths. Its role has grown significantly, rising from 22.8% of overdose deaths in 2017 to over 52% in 2021.
In many cases, methamphetamine isn’t used alone. Research from West Virginia University shows that most people in treatment are using both opioids and methamphetamine.
People use these drugs together for different reasons:
- Some combine them intentionally for different effects
- Others use stimulants to stay awake or alert
- Some don’t realize they’re using multiple substances
Toxicology reports often show fentanyl or benzodiazepines in people who believed they were only using methamphetamine.
Why Polysubstance Use Makes Treatment Harder
This pattern of using multiple drugs at once, called polysubstance use, makes treatment more complicated.
- There are effective medications for opioid use disorder
- There’s no FDA-approved medication for methamphetamine use disorder
- Patients often need treatment for both at the same time
This creates gaps in care. West Virginia’s state plan has identified a need for more training and support related to stimulant use and polysubstance treatment.
Why the Problem Persists Despite Significant Investment
West Virginia has not ignored its overdose crisis. The state has taken a wide range of actions, including:
- Expanding its prescription drug monitoring program
- Increasing access to medication-assisted treatment through hub-and-spoke models
- Deploying Quick Response Teams in high-risk areas
- Distributing naloxone at a large scale
- Establishing the Governor’s Council on Substance Abuse
A 2021 analysis estimated the state spends about $11.3 billion each year on the direct and indirect costs of its drug crisis.
Even with this level of investment, progress has been limited. As one state policy advisor said in 2024, “We’re nowhere near where we need to be.” Several factors help explain why.
Economic Conditions Have Not Changed
The underlying economic challenges that contribute to substance use have not improved in a meaningful way. Poverty remains high, and many communities have not recovered from the loss of coal jobs.
Treatment can help individuals recover, but it cannot fully address broader issues like economic instability, unemployment and long-term community decline.
The Drug Supply Has Outpaced Treatment
The shift to fentanyl and polysubstance use has created new challenges that the current treatment system was not designed to handle.
Medications like buprenorphine, methadone and naltrexone are still effective for opioid use disorder. However, they don’t fully address the growing role of methamphetamine use, which often occurs at the same time.
Workforce and Access Barriers Remain
West Virginia continues to face major challenges in delivering care.
- There’s a shortage of behavioral health providers
- Rural geography makes transportation difficult
- The healthcare system serves a small, older and lower-income population
In addition, changes to Medicaid coverage in 2023 disrupted treatment access for some patients, making an already difficult situation more unstable.
Policy Approaches Are Still Evolving
Policy decisions have not always focused on expanding treatment access.
In 2024, state lawmakers chose not to pass a bill aimed at improving access to care. Instead, attention shifted toward increasing penalties for drug possession. Research shows that punitive approaches alone are not effective in addressing addiction.
The 2024 Decline: Genuine Progress With Caveats
The overdose death numbers for West Virginia in 2024 are meaningfully better than in the previous four years. The decline is real. A reduction of more than 35% in a single year represents hundreds of lives saved.
West Virginia also outpaced the national average decline. This suggests that some state-level efforts are making a difference, including:
- Expanded naloxone distribution
- Quick Response Teams
- Increased access to medication-assisted treatment
- Harm reduction programs
Why Experts Urge Caution
Even with this progress, experts say the numbers should be interpreted carefully.
Some of the improvement reflects a return toward pre-pandemic levels rather than a long-term change. Overdose deaths rose sharply during the pandemic, and part of the recent decline may be a correction from that spike.
State experts also note that returning to earlier levels isn’t enough. To show real progress, overdose rates need to fall below pre-pandemic levels, not just return to them.
Even after these declines, West Virginia still has one of the highest overdose death rates in the country. In 2024, the rate was about 38.6 deaths per 100,000 people.
Getting Help
If you or someone you know in West Virginia is struggling with opioid, methamphetamine or polysubstance use, help is available.
NationalRehabHotline.org is a free, confidential referral service available 24-7. We can help you:
- Find treatment programs in West Virginia or nearby areas
- Identify options that accept Medicaid or private insurance
- Locate programs that offer sliding-scale fees
- Understand next steps, including transportation and prior authorization
You don’t have to figure this out alone. Support is available, and taking the first step can make a difference.
